Australia and New Zealand Ultrasound Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

The Australia and New Zealand ultrasound devices market was valued at USD 380.47 Million in 2025 and is expected to grow at a CAGR of 6.07%, reaching USD 685.88 Million by 2035. Market growth is supported by increasing use in diagnostic imaging and prenatal care.

Q1 2026 Market Updates

Geopolitical Impact of Iran, US, and Israel War on the Australia and New Zealand Ultrasound Devices Market

United States: The United States is the dominant supplier of ultrasound device technology to Australia and New Zealand, with GE Healthcare, Philips, and Siemens Healthineers providing the majority of hospital and point-of-care ultrasound equipment to the region. The Iran war's impact on the ANZ ultrasound devices market is primarily through pharmaceutical and medical consumable supply chain costs, logistics cost inflation, and healthcare budget pressures. Australia's wholesale diesel price rose to AUD 2.45 per litre by March 23, 2026, and the government relaxed fuel quality standards for diesel, signalling acute fuel supply concerns. Australia's healthcare system faces modest budget pressure from rising energy costs, which may moderate capital equipment procurement timelines.

Iran: Iran had been working to develop domestic medical imaging capabilities, but was severely constrained by sanctions that limited access to advanced ultrasound technology from Western suppliers. The conflict has entirely eliminated what limited medical imaging capacity existed in the country. The broader humanitarian consequences include the WHO identifying 13 Iranian health facilities as conflict-damaged, eliminating diagnostic imaging services for a large civilian population.

Israel: Israel is a significant medical device innovation hub with companies including InSightec and other ultrasound technology developers. The conflict has disrupted commercial operations at some Israeli medical technology companies, and the Israeli healthcare system is under extreme pressure from managing large numbers of conflict casualties while maintaining civilian healthcare services. Israeli ultrasound technology companies with partnerships in ANZ markets have suspended business development activities during the conflict period.

Key Takeaways

Government

• The Australian Department of Health should ensure that ultrasound device procurement timelines under public hospital capital programmes are not delayed by logistics cost inflation, recognising that diagnostic imaging is a critical healthcare infrastructure requirement.
• New Zealand's Ministry of Health should review the resilience of its ultrasound device supply chain, assessing whether the elevated freight costs and extended lead times from conflict-disrupted global logistics will affect planned equipment replacement cycles.
• ANZ health authorities should work with GE Healthcare, Philips, and other suppliers to explore regional stocking arrangements for critical spare parts and transducer components, reducing the impact of air freight cost surges on maintenance and repair timelines.

Market

• The ANZ ultrasound devices market faces modest logistics cost inflation from the conflict, with ocean freight costs up 30% and air freight costs spiking for time-sensitive components, inflating the total cost of device procurement and ongoing maintenance.
• The fundamental demand drivers for ultrasound in ANZ, including aging populations, growing chronic disease burden, and expansion of point-of-care ultrasound adoption in emergency medicine, remain structurally intact and independent of the conflict.
• Australia's energy cost pressures from disrupted LNG supply, with Qatari LNG force majeure affecting some Australian import partners, may create marginal healthcare facility operating cost increases that modestly slow capital equipment purchase decisions.

Procurement

• ANZ hospital procurement teams should review their ultrasound device replacement and upgrade schedules, checking whether any planned purchases rely on components or models with supply chains routed through Gulf-affected logistics corridors.
• Healthcare procurement managers should work with device manufacturers to ensure that service contracts include adequate provisions for spare parts availability given elevated logistics costs and the potential for extended delivery timelines.
• Radiology departments should assess transducer maintenance programmes and increase inspection frequency, ensuring that any delay in transducer replacement from logistics disruptions does not create diagnostic capability gaps.